Coarse facial features
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cockayne Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Moreover, mutations in the TFIIH subunits XPB and XPD found in Cockayne syndrome impair the interaction of TFIIH with the rDNA, but do not influence initiation complex formation or promoter escape of RNA polymerase I, but preclude the productivity of the enzyme by reducing transcription elongation in vivo and in vitro.
|
21965540 |
2012 |
Cockayne Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Inborn defects in nucleotide excision DNA repair (NER) can paradoxically result in elevated cancer incidence (xeroderma pigmentosum [XP]) or segmental progeria without cancer predisposition (Cockayne syndrome [CS] and trichothiodystrophy [TTD]).
|
16904611 |
2006 |
Cockayne Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
These results suggest that the XPG-TFIIH complex is involved in transcription elongation and that defects in this association may partly account for Cockayne syndrome in XP-G/CS patients.
|
26149386 |
2015 |
Cockayne Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Subtle differences in the effects of these different mutations on the many activities of TFIIH and on its stability determine the clinical outcomes, which can be XP, TTD, XP with CS, XP with TTD or COFS.
|
14726016 |
2003 |
Cockayne Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients.
|
17466625 |
2007 |
Cockayne Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
All three are genetically complex, with at least eight complementation groups for XP (XP-A to -G and variant), five for CS (CS-A, CS-B, XP-B, XP-D, and XP-G), and three for TTD (XP-B, XP-D, and TTD-A).
|
11037299 |
2001 |
Cockayne Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mapping disease mutations associated with xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome onto defined communities reveals clustering into three mechanistic classes that affect TFIIH helicase functions, protein interactions and interface dynamics.
|
31110295 |
2019 |
Cockayne Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mutations in certain subunits of the DNA repair/transcription factor complex TFIIH are linked to the human syndromes xeroderma pigmentosum (XP), Cockayne's syndrome (CS), and trichothiodystrophy (TTD).
|
19008953 |
2008 |
Cockayne Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutation of CSB, CSA, or the TFIIH helicases XPB and XPD can also cause defective TCR and CS.
|
16246722 |
2005 |
Cockayne Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mutations in the DNA-dependent ATPase/helicase subunits of TFIIH, XPB and XPD, are associated with three inherited syndromes as follows: xeroderma pigmentosum with or without Cockayne syndrome and trichothiodystrophy.
|
10660593 |
2000 |
Cockayne Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
A recent report provides a molecular basis for how mutations in the NER endonuclease XPG that affect the interaction of TFIIH might give rise to CS features.
|
18077223 |
2008 |
Cockayne Syndrome, Type I
|
0.010 |
Biomarker
|
disease |
BEFREE |
Knockdown of CSA reduces pre-rRNA synthesis by RNA polymerase I. CSA associates with RNA polymerase I and the active fraction of the rDNA and stimulates re-initiation of rDNA transcription by recruiting the Cockayne syndrome proteins TFIIH and CSB.
|
24781187 |
2014 |
Colorectal Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study.
|
22363067 |
2012 |
Colorectal Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
TTD consensus document on the diagnosis and management of hereditary colorectal cancer.
|
20466620 |
2010 |
Congenital Epicanthus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital exfoliative erythroderma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital exomphalos
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital Nonbullous Ichthyosiform Erythroderma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Contracture of joint of hand
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cortical cataract
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
These results suggest that the XPG-TFIIH complex is involved in transcription elongation and that defects in this association may partly account for Cockayne syndrome in XP-G/CS patients.
|
26149386 |
2015 |
Cortical cataract
|
0.020 |
Biomarker
|
disease |
BEFREE |
Mutations in XPG found in XP-G/CS patient cells that prevent the association with TFIIH also resulted in the dissociation of CAK and XPD from the core TFIIH.
|
17466625 |
2007 |
Craniosynostosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cryptorchidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Decreased fertility
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|